No black box warning on record for Neostigmine Methylsulfate

As of the latest FDA labeling reviewed, Neostigmine Methylsulfate (NEOSTIGMINE METHYLSULFATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Neostigmine Methylsulfate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Bradycardia : Atropine or glycopyrrolate should be administered prior to administration of neostigmine methylsulfate injection to lessen risk of bradycardia ( 5.1 ) Coexisting Conditions : patients with known cardiac disease, cardiac arrhythmias, or recent coronary artery occlusion may be particularly sensitive to the hemodynamic effects of neostigmine; their blood press

No black box warning on record for Neostigmine Methylsulfate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Bradycardia : Atropine or glycopyrrolate should be administered prior to administration of neostigmine methylsulfate injection to lessen risk of bradycardia ( 5.1 ) Coexisting Conditions : patients with known cardiac disease, cardiac arrhythmias, or recent coronary artery occlusion may be particularly sensitive to the hemodynamic effects of neostigmine; their blood press

Neostigmine Methylsulfate Black Box Warning

No black box warning on record for Neostigmine Methylsulfate

Other warnings & precautions

Neostigmine Methylsulfate Black Box Warning

No black box warning on record for Neostigmine Methylsulfate

Other warnings & precautions